These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 7313308

  • 1. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA.
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tetraalkylammonium ions: protection of murine L1210 leukemia and bone marrow progenitor cells in vitro against mechlorethamine cytotoxicity and inhibition of the choline transport system.
    Naujokaitis SA, Fisher JM, Rabinovitz M.
    Chem Biol Interact; 1982 Jun; 40(2):133-40. PubMed ID: 7083390
    [Abstract] [Full Text] [Related]

  • 4. Protection of murine L1210 leukemia and bone marrow progenitor cells against mechlorethamine and inhibition of choline uptake as a structure-activity relationship of 2-dimethylaminoethanol and its analogues.
    Naujokaitis SA, Fisher JM, Rabinovitz M.
    J Pharm Sci; 1984 Jan; 73(1):34-9. PubMed ID: 6694079
    [Abstract] [Full Text] [Related]

  • 5. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA.
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R, Bony V, Lopez M.
    Prog Clin Biol Res; 1994 May; 389():23-9. PubMed ID: 7700906
    [No Abstract] [Full Text] [Related]

  • 7. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC, Green D, Schein PS.
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [Abstract] [Full Text] [Related]

  • 8. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
    van Pel M, Hagoort H, Hamann J, Fibbe WE.
    Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
    [Abstract] [Full Text] [Related]

  • 9. 6-[Bis(2-chloroethyl)amino]-6-deoxygalactopyranose hydrochloride (C6-galactose mustard), a new alkylating agent with reduced bone marrow toxicity.
    Schein PS, Green D, Dean SW, McPherson E.
    Cancer Res; 1987 Feb 01; 47(3):696-9. PubMed ID: 3802075
    [Abstract] [Full Text] [Related]

  • 10. Prediction of the ability to purge tumor from murine bone marrow using clonogenic assays.
    Jones RJ, Colvin OM, Sensenbrenner LL.
    Cancer Res; 1988 Jun 15; 48(12):3394-7. PubMed ID: 3285994
    [Abstract] [Full Text] [Related]

  • 11. Cyclophosphamide. I. Effects of survival and colony-forming cells in BDF1 L-1210-bearing mice.
    Pazdernik TL, Uyeki EM.
    J Pharmacol Exp Ther; 1978 Oct 15; 207(1):255-61. PubMed ID: 702348
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA, Vietti T, Valeriote F.
    Cancer Res; 1975 Aug 15; 35(8):1926-30. PubMed ID: 50128
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
    Prakash NJ, Sunkara PS.
    Cancer Res; 1983 Jul 15; 43(7):3192-6. PubMed ID: 6406054
    [Abstract] [Full Text] [Related]

  • 14. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
    Hemmi H.
    Res Commun Chem Pathol Pharmacol; 1981 Jun 15; 32(3):565-8. PubMed ID: 6791252
    [Abstract] [Full Text] [Related]

  • 15. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H, Uitendaal MP, van der Grint L, Leyva A, Pinedo HM.
    Cancer Res; 1981 Mar 15; 41(3):1193-8. PubMed ID: 6970074
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Histidinol-mediated enhancement of the specificity of two anticancer drugs in mice bearing leukemic bone marrow disease.
    Warrington RC, Fang WD.
    J Natl Cancer Inst; 1985 May 15; 74(5):1071-7. PubMed ID: 3858576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.